Source: BIO PORTFOLIO

Separation Technology: EKF Diagnostics Acquires Separation Technology Inc.

Hematology testing company complements EKF’s POCT product portfolio. The UltraCrit is the first and only hematocrithemoglobin device to use ultrasound technologyEKF Diagnostics the global in vitro diagnostics business announces that it has acquir...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more